논문상세정보

' 한국형 치매임상진료지침 소개' 의 참고문헌

  • Ott A Lancet 351 1840-1843 [1998]
  • 혈관성 인지장애 선별검사로서 Korean-Montreal Cognitive Assessment(K-MoCA)의 신뢰도, 타당도 및 규준 연구
    강연욱 한국심리학회지 임상 28 2 549-562 [2009]
  • 한국판 Modified Mini-Mental State (K-3MS) Examination의 타당도
    손은희 대한신경과학회지 21 4 4-356 [2003]
  • 한국판 Instrumental Activities of Dalily Living의 타당도와 신뢰도
    강수진 대한신경과학회지 20 1 8-14 [2002]
  • 한국판 Global Deterioration Scale의 타당도
    최성혜 대한신경과학회지 20 6 612-617 [2002]
  • 한국판 7분 치매 선별 검사의 타당도 연구
    박민선 Korean Journal of Family Medicine 23 2 5-739 [2002]
  • 한국어판 하세가와 치매척도 개정본의 신뢰도 및 타당도의 평가
    양동원 대한신경과학회지 22 4 315-321 [2004]
  • 치매 선별을 위한 한국어판 하세가와 치매척도의 신뢰도와 타당도
    김기웅 신경정신의학 41 3 526-537 [2002]
  • 치매 선별용 간이정신상태검사(Mini-Mental State Examination for Dementia Screening;MMSE-DS)와 단축형 MMSE-DS(SMMSE-DS)의 한국 노인 정상규준 연구
    한지원 노인정신의학 14 1 27-37 [2010]
  • 일상활동평가-복합(Seoul-Instrumental Activities of Daily Living ; S-IADL)의 신뢰도 및 타당도 연구
    구형모 신경정신의학 43 2 189-199 [2004]
  • Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
    Roman GC Neurology 43 250-260 [1993]
  • Vascular dementia: a radical redefinition
    Hachinski V Dementia 5 130-132 [1994]
  • Vascular dementia in a populationbased autopsy study
    Knopman DS Arch Neurol 60 569-575 [2003]
  • Validation of the Korean version of the Bayer activities of daily living scale
    Choi SH Hum Psychopharmacol 18 469-475 [2003]
  • Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s Disease
    Mayeux R N Engl J Med 338 506-511 [1998]
  • The validity and reliability of the Samsung Dementia Questionnaire (SDQ)
    Choi SH J Korean Neurol Assoc 16 307-314 [1998]
  • The validity and reliability of the Korean version of Severe Impairment Battery
    Na HR Dement Neurocogn Disord 5 70-76 [2006]
  • The socioeconomic cost analysis-oriented to the dementia patients using medical service
    Kang IO - [2005]
  • The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis
    Gao S Arch Gen Psychiatry 55 809-815 [1998]
  • The prevalence of dementia in older people in an urban population of Korea: the Seoul study
    Lee DY J Am Geriatr Soc 50 1233-1239 [2002]
  • The prevalence of dementia in a metropolitan city of South Korea
    Kim J Int J Geriatr Psychiatry 18 617-622 [2003]
  • The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients
    Choi SH J Korean Med Sci 15 609-615 [2000]
  • The Behavior Pathology in Alzheimer’s Disease Rating Scale, Korean version (BEHAVE-AD-K): factor structure among Alzheimer’s disease inpatients
    Suh GH J Korean Geriatr Psychiatry 5 86-95 [2001]
  • The Bayer Activities of Daily Living Scale
    Hindmarch I Dement Geriatr Cogn Disord 9 Suppl 2 20-26 [1998]
  • The AD8: a brief informant interview to detect dementia
    Galvin JE Neurology 65 559-564 [2005]
  • The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
    Hsich G N Engl J Med 335 924-930 [1996]
  • Statins and the risk of dementia
    Jick H Lancet 356 1627-1631 [2000]
  • Social index survey
  • Seoul neuropsychological screening battery
    Kang YW - [2003]
  • Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients
    안현정 Journal of Korean Medical Science 25 7 1071-1076 [2010]
  • Scottish Intercollegiate Guidelines Network Management of patients with dementia: A national clinical guideline
    - [2006]
  • Risk of dementia and alcohol and wine consumption: a review of recent results
    Letenneur L Biol Res 37 189-193 [2004]
  • Reliability and Validity of the Severe Impairment Battery (SIB) in Korean Dementia Patients
    Inn Sook Ahn Journal of Korean Medical Science 21 3 506-517 [2006]
  • Relationship of Down’s syndrome to Alzheimer’s disease, in Application of basic neuroscience to child
    Rabe A 325-339 [1990]
  • Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline
    Waldemar G Eur J Neurol 14 e1-26 [2007]
  • Psychopathology of very mild dementia of the Alzheimer type
    Rubin EH Am J Psychiatry 146 1017-1021 [1989]
  • Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset
    Brookmeyer R Am J Public Health 88 1337-1342 [1998]
  • Prevalence of dementia in the elderly of an urban community in Korea
    Kim DH Korean J Prev Med 32 306-316 [1999]
  • Prevalence of cognitive impairment and depressive symptoms among the elderly in an urban community
    Cho MJ J Korean Neuropsychiatr Assoc 37 352-362 [1998]
  • Prevalence estimation of dementia in a rural area of Korea
    Woo JI J Am Geriatr Soc 46 983-987 [1998]
  • Predicting conversion to Alzheimer disease using standardized clinical information
    Daly E Arch Neurol 57 680- [2000]
  • Practice parameter:early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Petersen RC Neurology 56 1133-1142 [2001]
  • Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Doody RS Neurology 56 1154-1166 [2001]
  • Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Knopman DS Neurology 56 1143-1153 [2001]
  • Pathological verification of ischemic score in differentiation of dementias
    Rosen WG Ann Neurol 7 486-488 [1980]
  • Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease
    Kivipelto M Arch Neurol 62 1556-1560 [2005]
  • New insights into the genetics of Alzheimer’s disease
    Hardy J Ann Med 28 255-258 [1996]
  • Nationwide study on the prevalence of dementia in Korean elders
  • Mini-mental state : A practical method for grading the cognitive state of patients for the clinician
    Folstein, M. F. J Psychiatr Res 12 189-198 [1975]
  • Mild cognitive impairment: clinical characterization and outcome
    Petersen RC Arch Neurol 56 303-308 [1999]
  • Mild cognitive impairment: beyond controversies, towards a consensus:report of the International Working Group on Mild Cognitive Impairment
    Winblad B J Intern Med 256 240-246 [2004]
  • Mild cognitive impairment in the elderly: predictors of dementia
    Flicker C Neurology 41 1006-1009 [1991]
  • Metaanalysis of nonsteroidal antiinflammatory drug use and risk of dementia
    De Craen AJ Am J Epidemiol 161 114-120 [2005]
  • Manual for guideline adaptation ver 1.0
    Kim SY - [2009]
  • Leisuretime physical activity at midlife and the risk of dementia and Alzheimer’s disease
    Rovio S Lancet Neurol 4 705-711 [2005]
  • Korean version of Mini-Mental State Examination (MMSE-K) part : development of the test for the elderly
    Kwon YC J Korean Neuropsychiatr Assoc 28 125-135 [1989]
  • Korean Dementia Screeing Questionnaire (KDSQ)의 개발과 타당도 및 신뢰도의 평가
    양동원 대한신경과학회지 20 2 135-141 [2002]
  • K-MMSE(Korean-Mini Mental State Examination)의 노인 규준 연구
    강연욱 한국심리학회지:일반 25 2 1-12 [2006]
  • Is depression a risk factor for dementia or cognitive decline? A review
    Jorm AF Gerontology 46 219-227 [2000]
  • Introduction to behavioural and psychological symptoms of dementia
    Finkel S Int J Geriatr Psychiatry 15 Suppl 1 S2-S4 [2000]
  • Influence of education and occupation on the incidence of Alzheimer’s disease
    Stern Y JAMA 271 1004-1010 [1994]
  • ICD-10: international statistical classification of diseases and related health problems. 10th ed
  • Head injury and the risk of AD in the MIRAGE study
    Guo Z Neurology 54 1316-1323 [2000]
  • Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004
    Brainin M Eur J Neurol 11 577-581 [2004]
  • Genetic susceptibility and head injury as risk factors for Alzheimer’s disease among community-dwelling elderly persons and their first-degree relatives
    Mayeux R Ann Neurol 33 494-501 [1993]
  • Galantamine maintains ability to perform activities of daily living in patients with Alzheimer’s disease
    Galasko D J Am Geriatr Soc 52 1070-1076 [2004]
  • Functional evaluation: the barthel index
    Mahoney FI Md State Med J 14 61-65 [1965]
  • Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence fin-dings
    Rocca WA Ann Neurol 30 381-390 [1991]
  • Forgetful but not forgotten
  • Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
    Cruts M Hum Mol Genet 7 43-51 [1998]
  • Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale
    Choi SH J Korean Neurol Assoc 19 585-591 [2001]
  • Epidemiologic transition in dementia-cross-national comparisons of the indices related to Alzheimer’s disease and vascular dementia: epidemiologic transition in dementia
    Suh GH J Korean Geriatr Psychiatry 4 173-185 [2000]
  • Elderly memory disorder scale
    Chey JY - [2007]
  • Diagnostic and statistical manual of mental disorders. 4th ed
  • Development of the norms for the Korean Dementia Rating Scale
    Chey JY Korean J Clin Psychol 16 423-433 [1997]
  • Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries
    Lee JH J Gerontol B Psychol Sci Soc Sci 57 P47-P53 [2002]
  • Development of the Korean version of Alzheimer’s Disease Assessment Scale
    Youn JC Int J Geriatr Psychiatry 17 797-803 [2002]
  • Development of the Korean Version of Disability Assessment for Dementia Scale(DAD-K) to assess function in dementia
    Suh GH J Korean Geriatr Soc 7 278-287 [2003]
  • Development of a Korean version of the Behavior Rating Scale for Dementia
    Youn JC Int J Geriatr Psychiatry 23 677-684 [2008]
  • Dementia: the NICE-SCIE guideline on supporting people with dementia and their carers in health and social care
  • Dementia among the elderly in a rural Korean community
    Park J Br J Psychiatry 164 796-801 [1994]
  • Current concepts in mild cognitive impairment
    Petersen RC Arch Neurol 58 1985-1992 [2001]
  • Cortical abnormalities in Alzheimer’s disease
    Foster NL Ann Neurol 16 649-654. [1984]
  • Contribution of structural neuroimaging to the early diagnosis of Alzheimer’s disease
    De Leon MJ Int Psychogeriatr 9 Suppl 1 183-190 [1997]
  • Comparison of two screening tests in dementia: the Mini-Mental State Examination (MMSE) and the revised Hasegawa’s Demential Scale
    Kang YW J Korean Neurol Assoc 17 Suppl 2 82-83 [1999]
  • Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease
    McKhann G Neurology 34 939-944 [1984]
  • CSF markers for incipient Alzheimer’s disease
    Blennow K Lancet Neurol 2 605-613 [2003]
  • CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease
    Andreasen N Clin Neurol Neurosurg 107 165-173 [2005]
  • CSF Abeta 42 levels correlate with amyloid-neuropathology in a populationbased autopsy study
    Strozyk D Neurology 60 652-656 [2003]
  • Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment
    Lee JY J Geriatr Psychiatry Neurol 21 104-110 [2008]
  • Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases
    Verbeek MM Ann Clin Biochem 40 Pt 1 25-40 [2003]
  • Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
    Snowdon DA JAMA 277 813-817 [1997]
  • Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer’s disease
    Agdeppa ED J Neurosci 21 RC189- [2001]
  • Apolipoprotein E: highavidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
    Strittmatter WJ Proc Natl Acad Sci U S A 90 1977-1981 [1993]
  • APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease
    Schellenberg GD Am J Hum Genet 49 511-517 [1991]
  • A study on the reliability and validity of Seoul-Activities of Daily Living
    Ku HM J Korean Geriatr Soc 8 206-214 [2004]
  • A short form of the Samsung Dementia Questionnaire (S-SDQ): development and crossvalidation
    Choi SH J Korean Neurol Assoc 17 253-258 [1999]
  • 15-year longitudinal study of blood pressure and dementia
    Skoog I Lancet 347 1141-1145 [1996]